Literature DB >> 8375586

Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin.

P A Jansson1, J P Fowelin, H P von Schenck, U P Smith, P N Lönnroth.   

Abstract

To evaluate the interstitial insulin and inulin concentrations, 20-min microdialysis samples from the abdominal subcutaneous tissue were obtained by using two 45-mm polypropylene dialyzing tubes (o.d. approximately 0.5 mm, pore size 0.2 micron) during a euglycemic hyperinsulinemic (120 mU.m-2 x min-1) clamp (n = 9) or during a constant inulin infusion (n = 5). After in situ calibration of the microdialysis catheters during steady-state conditions, interstitial and plasma insulin concentrations were estimated to 654 +/- 102 and 1176 +/- 66 pM, respectively, i.e., a 44% difference (P < 0.001). A doubling of the insulin infusion rate (240 mU.m-2 x m-1), leading to supraphysiological plasma insulin levels, raised the interstitial insulin concentrations markedly slower (approximately 20 min) than in plasma. Moreover, at steady state the concentration difference in the two compartments prevailed even during the high insulin infusion rate (55% difference, P < 0.01). In contrast, the interstitial inulin levels were similar to the plasma concentrations in subjects given a constant inulin infusion. Thus, the data suggest the presence of an endothelial barrier for insulin in the subcutaneous tissue. This barrier, in combination with tissue clearance of insulin, leads to lower insulin levels and altered kinetics with a slower rise in the interstitial fluid compared with plasma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375586     DOI: 10.2337/diab.42.10.1469

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  29 in total

Review 1.  Science, medicine, and the future: Microdialysis.

Authors:  Markus Müller
Journal:  BMJ       Date:  2002-03-09

Review 2.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 3.  The role of endothelial insulin signaling in the regulation of glucose metabolism.

Authors:  Tetsuya Kubota; Naoto Kubota; Takashi Kadowaki
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 4.  Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.

Authors:  Eugene J Barrett; Hong Wang; Charles T Upchurch; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-24       Impact factor: 4.310

5.  The Endothelial Barrier Is not Rate-limiting to Insulin Action in the Myocardium of Male Mice.

Authors:  Rajiv Sanwal; Negar Khosraviani; Suzanne L Advani; Andrew Advani; Warren L Lee
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

6.  Insulin permeability across an in vitro dynamic model of endothelium.

Authors:  Francesca Salvetti; Paolo Cecchetti; Damir Janigro; Antonio Lucacchini; Luca Benzi; Claudia Martini
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

7.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans.

Authors:  R L Prigeon; M E Røder; D Porte; S E Kahn
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

8.  The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

Authors:  D Turk; A Alzaid; S Dinneen; K S Nair; R Rizza
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

9.  Development of a Microsphere-Based System to Facilitate Real-Time Insulin Monitoring.

Authors:  Lindy Kahanovitz; Erkin Seker; Robert S Marks; Martin L Yarmush; Tania Konry; Steven J Russell
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

10.  Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans.

Authors:  P Vollenweider; D Randin; L Tappy; E Jéquier; P Nicod; U Scherrer
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.